Histopathologic differences account for racial disparity in uterine cancer survival

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 616-619

  Smotkin, David ^a   Nevadunsky, Nicole S ^a   Harris, Kimala ^a   Einstein, Mark H ^a   Yu, Yiting ^a   Goldberg, Gary L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Disparity; Histology; Racial; Survival; Uterine cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; DEMOGRAPHY; ENDOMETRIUM BIOPSY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RACE; UTERUS CANCER;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; UTERINE NEOPLASMS;

EID: 84868600198     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.025     Document Type: Conference Paper

References (15)

1. American Cancer Society Cancer facts & figures 2010 American Cancer Society Atlanta
2. M. Sherman, and S. Devesa Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus Cancer 98 1 2003 176 185
3. P.B. Bach, D. Schrag, O.W. Brawley, A. Galaznik, S. Yakren, and C.B. Begg Survival of blacks and whites after a cancer diagnosis JAMA 287 16 2002 2106 2113
4. V.M. Setiawan, M.C. Pike, L.N. Kolonel, A.M. Nomura, M.T. Goodman, and B.E. Henderson Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study Am J Epidemiol 165 3 2007 262 270
5. M.L. Hicks, J.L. Phillips, G. Parham, N. Andrews, W.B. Jones, and H.M. Shingleton The National Cancer Data Base report on endometrial carcinoma in African-American women Cancer 83 12 1998 2629 2637
6. J.D. Wright, J. Fiorelli, P.B. Schiff, W.M. Burke, A.L. Kansler, and C.J. Cohen Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time Cancer 115 6 2009 1276 1285
7. S. Pecorelli, J.L. Benedet, W.T. Creasman, and J.H. Shepherd FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics Int J Gynecol Obstet 64 1 1999 5 10
8. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am J Surg Pathol 6 2 1982 93 108
9. S.M. Ueda, D.S. Kapp, M.K. Cheung, J.Y. Shin, K. Osann, and A. Husain Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths Am J Obstet Gynecol 198 2 2008 218.e1 218.e6
10. M.E. Sherman, P. Bitterman, N.B. Rosenshein, G. Delgado, and R.J. Kurman Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features Am J Surg Pathol 16 6 1992 600 610
11. B.A. Goff, D. Kato, R.A. Schmidt, M. Ek, J.A. Ferry, and H.G. Muntz Uterine papillary serous carcinoma: patterns of metastatic spread Gynecol Oncol 54 3 1994 264 268
12. A.N. Fader, D. Starks, P.A. Gehrig, A.A. Secord, H.E. Frasure, and D.M. O'Malley For the UPSC Consortium. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC) Gynecol Oncol 115 2 2009 244 248
13. S.E. Brooks, M. Zhan, T. Cote, and C.R. Baquet Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol Oncol 93 1 2004 204 208
14. R.P. Matthews, J. Hutchinson-Colas, M. Maiman, R.G. Fruchter, E.J. Gates, and D. Gibbon Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women Gynecol Oncol 65 2 1997 206 212
15. Z. Al-Wahab, R. Ali-Fehmi, M.L. Cote, M.A. Elshaikh, D.R. Ibrahim, and A. Semaan The impact of race on survival in uterine serous carcinoma: a hospital-based study Gynecol Oncol 121 3 2011 577 580